SAGE: Total Utang marang Modal Sage Therapeutics

Logo perusahaan publik Sage Therapeutics (SAGE)

The financial price visualization for Sage Therapeutics, Inc. (SAGE) demonstrates a debt-to-equity ratio of 0.03. The business relies on the development of antidepressants, for which demand is independent of economic cycles and seasonality. High brand authority among scientists is coupled with a pragmatic outlook from shareholders. However, geopolitical tensions and sanctions are seriously hindering global testing and the logistics of biomaterials.

SAGE - Total Utang marang Modal Sage Therapeutics ing rentang 04.07.2022 - 16.08.2025

Rincian metrik lan analitis perusahaan Sage Therapeutics Inc (SAGE)

- rega lan prakiraan konsensus rega:
Bagan rega Sage Therapeutics|SAGE - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Sage Therapeutics|SAGE - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Sage Therapeutics|SAGE - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku sagerx.com|SAGE - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Sage Therapeutics, Inc.|SAGE - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sage Therapeutics, Inc.|SAGE - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Sage Therapeutics|SAGE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sage Therapeutics|Rasio cepet sagerx.com
- statistik bathi lan rasio pasar:
SAGE - Penghasilan resik perusahaan
Analisis wiwitan perusahaan:Sage Therapeutics, SAGE
Barang utama Sage Therapeutics, Inc.

Despite Zurzuvae's patent exclusivity, insurance reimbursement barriers are limiting revenue, making debt load control critical for Sage Therapeutics, Inc. (SAGE). The current total debt-to-equity ratio of 0.03 measures the proportion of borrowed funds within the balance sheet structure, allowing investors to assess financial stability and default risk by analyzing the trends on this chart.

Pesaing utama

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|biohavenpharma.com (BHVN) - Koefisien Total Utang marang Modal|Total Utang marang Modal AMLX|Total Utang marang Modal Trevi Therapeutics Inc (TRVI)|Total Utang marang Modal PRAX (Praxis Medicines)|Rasio Utang marang Modal Anavex Life Sciences Corp|CeriBell, Inc. - Total Utang marang Modal|Utang marang Modal Prothena Corporation PLC|ALEC (alector.com) - Rasio Total Utang marang Ekuitas|Annexon Biosciences - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas OMER|NGNE (Neurogene Therapeutics) - Utang Agregat marang Modal|Total Utang marang Modal ACIU|VYGR (voyagertherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NMRA (Neumora Therapeutics, Inc.)|Scilex Holding (SCLX) - Utang marang Modal|TVGN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACOG (Alpha Cognition)|CGTX: Total Utang marang Modal|inhibikase.com (IKT) - Total Utang marang Modal|Utang marang Ekuitas Cassava Sciences|Assertio Therapeutics - Utang Agregat marang Ekuitas|Total Utang marang Modal COYA|VTGN - Utang marang Modal|Ovid Therapeutics - Rasio Total Utang marang Ekuitas|Total Utang marang Modal acumenpharm.com ABOS|CRVO: Rasio Total Utang marang Ekuitas|Alterity Therapeutics - Utang Agregat marang Modal|CLNN: Total Utang marang Modal|PEPG - Koefisien Total Utang marang Modal|JUNS (Jupiter Neurosciences Inc) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas relmada.com (RLMD)|Utang marang Ekuitas Annovis Bio (ANVS)|Koefisien Total Utang marang Modal gracetx.com|Firefly Neuroscience Inc - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi KLTO|NeuroSense Therapeutics, Ltd. - Total Utang marang Modal|Koefisien Total Utang marang Modal revivapharma.com RVPH|metaviatx.com (MTVA) - Utang marang Ekuitas|Rasio Utang marang Ekuitas NRXS|HSDT (Helius Medical Technologies, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Passage Bio Corp (PASG)|Rasio Total Utang marang Ekuitas NEUP (Neuphoria Therapeutics Inc.)|Koefisien Total Utang marang Modal minervaneurosciences.com|Utang marang Ekuitas Athira Pharma ATHA|Koefisien Total Utang marang Modal Addex Therapeutics Ltd. (ADXN)|Alzamend - Total Utang marang Modal|CYCN - Total Utang marang Modal|PTIX: Total Utang marang Modal|Rasio Utang marang Modal Pasithea Therapeutics Corp. KTTA|CRGT (Cortigent Inc) - Total Utang marang Modal|Utang marang Modal Avenue Therapeutics Inc. ATXI|Utang marang Ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Rasio Utang marang Ekuitas|Total Utang marang Modal CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Utang marang Modal|ITCI: Rasio Total Utang marang Ekuitas|LBPH - Total Utang marang Modal|Marinus (MRNS) - Utang marang Ekuitas|NKGen Biotech Corp - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas NeuroBo Pharmaceuticals|Utang marang Modal synaptogen.com SNPX|Utang marang Ekuitas Trevena (TRVN)|Koefisien Total Utang marang Modal vigilneuro.com|Total Utang marang Modal WENA (Anew Medical)|Total Utang marang Modal Cerevel Corp CERE